In this review:
- Pyoderma gangrenosum: demographics, disease and treatment
- Currently available psoriasis drugs- latest updates from the literature
- Vulval Lichen Sclerosus: An Australian Management Consensus
- Pruritus ani
- Oral treatment of infantile haemangiomas
- Interventions to improve histopathological agreement
- Bullous pemphigoid and pemphigus: its incidence and mortality outcome in New Zealand
- Treatment options for bullous pemphigoid
- JAK and IL-23 inhibitors for the treatment of vitiligo
- Melasma: What’s new? What’s true?
- Pityriasis rubra pilaris treatment options
- Climate change and Australia’s healthcare systems
- Treating the difficult female pattern hair loss
- COVID: public health, science and politics
- Pharmaceutical Management for COVID-19 disease in the community
- COVID-19 vaccination in dermatology patients on immunomodulatory and biologic agents
- COVID-19 and immunomodulatory agents for severe cutaneous disease
Please login below to download this issue (PDF)